cannabis hopes drug
prescription cannabis drug biotech gw pharmaceuticals approved canada
drug treat central nervous system alleviate symptoms multiple sclerosis weeks shares gw pharma lost regulators evidence drug benefits canadian authorities sativex drug considered approval
canada diagnosed suffering condition patients smoke cannabis relieve symptoms
gw pharma sativex mouth spray legally sufferers canada drug approved representing landmark gw pharma patients final approval canada formality expects approval sativex delighted receive qualifying notice health canada forward receiving regulatory approval sativex canada gw pharma executive chairman dr geoffrey
granted gw pharma licence grow cannabis plant medical purposes satifex consists cannabis extract tetrahydrocannabinol cannabidiol cocktail proved effective treating patients arthritis thousands plants grown secret location english countryside hopes regulatory approval series delays sativex launch shares gw pharma
